Nile Therapeutics, Inc. (NLTX) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 123 transactions totaling $39.3M, demonstrating a bullish sentiment with $37.8M in net insider flow. The most recent transaction on Oct 5, 2023 involved a transaction of 57,049 shares valued at $0.
No significant insider buying has been recorded for NLTX in the recent period.
No significant insider selling has been recorded for NLTX in the recent period.
Based on recent SEC filings, insider sentiment for NLTX is bullish with an Insider Alignment Score of 98/100 and a net flow of $37.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Nile Therapeutics, Inc. (NLTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading NLTX stock, having executed 123 transactions in the past 90 days. The most active insider is L.p. 667, (Executive), who has made 4 transactions totaling $25.3M.
Get notified when executives and directors at NLTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 5, 2023 | Advisors (gp) Llc Baker Bros. | Executive | Exercise | 57,049 | $N/A | $0 | |
| Oct 5, 2023 | Advisors (gp) Llc Baker Bros. | Executive | Exercise | 535,601 | $N/A | $0 | |
| Aug 17, 2023 | Life Sciences Lp Baker Brothers | Executive | Purchase | 7,676 | $0.69 | $5.3K | |
| Aug 17, 2023 | Life Sciences Lp Baker Brothers | Executive | Purchase | 93,091 | $0.69 | $64.2K | |
| Aug 17, 2023 | Life Sciences Lp Baker Brothers | Executive | Purchase | 5,041 | $0.69 | $3.5K | |
| Aug 17, 2023 | Life Sciences Lp Baker Brothers | Executive | Purchase | 61,134 | $0.69 | $42.2K | |
| Aug 16, 2023 | Life Sciences Lp Baker Brothers | Executive | Purchase | 366 | $0.68 | $249 | |
| Aug 16, 2023 | Life Sciences Lp Baker Brothers | Executive | Purchase | 207,676 | $0.68 | $141.2K | |
| Aug 16, 2023 | Life Sciences Lp Baker Brothers | Executive | Purchase | 17,124 | $0.68 | $11.6K | |
| Aug 16, 2023 | Life Sciences Lp Baker Brothers | Executive | Purchase | 4,434 | $0.68 | $3.0K | |
| Aug 15, 2023 | Life Sciences Lp Baker Brothers | Executive | Purchase | 358 | $0.67 | $240 | |
| Aug 15, 2023 | Life Sciences Lp Baker Brothers | Executive | Purchase | 1,740,581 | $0.63 | $1.1M | Large |
| Aug 15, 2023 | Life Sciences Lp Baker Brothers | Executive | Purchase | 143,519 | $0.63 | $90.4K | |
| Aug 15, 2023 | Life Sciences Lp Baker Brothers | Executive | Purchase | 4,342 | $0.67 | $2.9K | |
| Aug 11, 2023 | Michael Smith Sean | Executive | Sale | 1,323 | $0.62 | $820 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 65 | $38.5M | 98.1% |
Sale(S) | 37 | $739.7K | 1.9% |
Exercise (Options)(X) | 2 | $0 | 0.0% |
Exercise(M) | 7 | $0 | 0.0% |
Gift(G) | 4 | $0 | 0.0% |
Disposition(D) | 2 | $0 | 0.0% |
Conversion(C) | 2 | $0 | 0.0% |
Award(A) | 4 | $0 | 0.0% |
Insiders at Nile Therapeutics, Inc. are accumulating shares at an accelerated pace. With 17 insiders making 123 transactions totaling $38.5M in purchases versus $739.7K in sales, the net buying activity of $37.8M signals strong executive confidence. L.p. 667, (Executive) leads the buying activity with $25.3M in transactions across all time.